Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine C-X-C motif ligand 10 (CXCL10), also known as Interferon gamma-induced protein 10 (IP-10) or small-inducible cytokine B10, is a small pro-inflammatory chemokine belonging to the CXC chemokine family. It plays a central role in immune cell trafficking and inflammation by binding primarily to the CXCR3 receptor. CXCL10 expression is strongly induced by interferon-gamma (IFN-γ) in various cell types. Elevated levels or dysregulation of CXCL10 have been implicated in numerous diseases, including cancer, viral infections, autoimmune diseases and renal diseases.
CXCL10 exerts its effects mainly through binding to the G-protein coupled receptor CXCR3 on target leukocyte subsets. This triggers downstream signaling cascades leading to calcium influx and cytoskeletal rearrangement required for directed migration ("chemotaxis"). Additional effects include modulation of apoptosis pathways via caspase activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine C-X-C motif ligand 10 (CXCL10).